KB407 (Nebulization)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05095246 (ClinicalTrials.gov)	March 8, 2022	27/8/2021	A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis	A Phase I Study of Inhaled KB407, a Replication-Incompetent, Non-Integrating Vector Expressing Human ...	Cystic Fibrosis	Biological: KB407 (Nebulization)	Krystal Biotech, Inc.	Novotech (Australia) Pty Limited	Recruiting	18 Years	N/A	All	13	Phase 1	Australia

First Previous1Next Last